4/16
07:30 am
orgo
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
Medium
Report
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
4/3
07:44 am
orgo
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case [Yahoo! Finance]
Medium
Report
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case [Yahoo! Finance]
4/3
07:30 am
orgo
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
Medium
Report
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
3/2
08:46 am
orgo
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/1
09:34 am
orgo
Organogenesis Holdings Inc. (NASDAQ: ORGO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $5.00 price target on the stock.
Medium
Report
Organogenesis Holdings Inc. (NASDAQ: ORGO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $5.00 price target on the stock.
2/29
09:13 pm
orgo
Organogenesis (ORGO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
High
Report
Organogenesis (ORGO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/29
04:51 pm
orgo
Organogenesis Holdings Inc (ORGO) Faces Revenue Decline in Q4 and FY 2023, Aims for Growth in 2024 [Yahoo! Finance]
High
Report
Organogenesis Holdings Inc (ORGO) Faces Revenue Decline in Q4 and FY 2023, Aims for Growth in 2024 [Yahoo! Finance]
2/29
04:26 pm
orgo
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance [Yahoo! Finance]
High
Report
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance [Yahoo! Finance]
2/29
04:05 pm
orgo
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
High
Report
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
2/15
11:30 pm
orgo
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Medium
Report
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
2/12
07:33 am
orgo
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference [Yahoo! Finance]
Medium
Report
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference [Yahoo! Finance]
2/12
07:30 am
orgo
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Medium
Report
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
2/8
09:00 pm
orgo
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Low
Report
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
2/8
04:24 pm
orgo
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024 [Yahoo! Finance]
Low
Report
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024 [Yahoo! Finance]
2/8
04:05 pm
orgo
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
Low
Report
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
2/7
07:36 am
orgo
Organogenesis Holdings Inc. (NASDAQ: ORGO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $5.00 price target on the stock.
Medium
Report
Organogenesis Holdings Inc. (NASDAQ: ORGO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $5.00 price target on the stock.